Interaction between dextran and human low density lipoproteins (LDL) observed using laser light scattering

Chemistry and Physics of Lipids

Volumn 110, Issue 2, 2001, Pages 173-181

  Rühlmann, Christof ^a   Thieme, Maik ^a   Helmstedt, Martin ^b  

^a Center of Internal Medicine   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Dextran; Light scattering; Low density lipoproteins

Indexed keywords

DEXTRAN; LOW DENSITY LIPOPROTEIN; POLYSACCHARIDE;

ARTICLE; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; INFUSION; LASER; LIGHT SCATTERING; LIPID METABOLISM; PLASMA; PRIORITY JOURNAL;

DEXTRANS; HUMANS; LASERS; LIPOPROTEINS, LDL; SCATTERING, RADIATION; VISCOSITY;

EID: 0342468758     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(00)00202-4     Document Type: Article

References (41)

1. Ala-Korpela M., Pentikäinen M.O., Korhonen A., Hevonoja T., Lounila J., Kovanen P.T. Detection of low-density lipoprotein particle fusion by proton nuclear magnetic resonance spectroscopy. J. Lipid Res. 39:1998;1705-1712.
2. Austin M.A., Newman B., Selby J.V., Edwards K., Mayer E.J., Krauss R.M. Genetics of LDL subclass phenotypes in women twins. Arterioscler. Thromb. 13:1993;687-695.
3. Barter P.J., Rajaram O.V., Liang H.Q., Rye K.A. Relationship between the size and phospholipid content of low density lipoproteins. Biochim. Biophys. Acta. 1166:1993;135-137.
4. Baudin I., Ricard A., Audebert R.C. Adsorption of dextrans and pullulans at the silica-water interface: hydrodynamic layer thickness measurements: role in the fouling pf ultrafiltration membranes. J. Colloid Interf. Sci. 138:1990;324-331.
5. Baumstark M.W., Kreutz W., Berg A., Frey I., Keul J. Structure of human low-density lipoprotein subfractions, determinated by X-ray small angle scattering. Biochim. Biophys. Acta. 1037:1990;48-57.
6. Baxter J.H., Goodman H.C., Allen J.C. Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis. J. Clin. Invest. 40:1961;490-498.
7. Blome G., Kerstell J., Svanborg A. The effect of dextran on plasma lipids. Acta Med. Scand. 183:1968;481-485.
8. Dautzenberg H., Rother G. Interpretation of light scattering from supermolecular structures in liquid systems by master curves. J. Polym. Sci. Part B Polym. Phy. 26:1983;353-366.
9. Gabr Y., Michael A., Dawoud S., Fahmy L., Assem N. Effect of gelatin infusions on blood serum lipid pattern. Arzneimittelforschung. 40:1990;761-762.
10. Grönwall A., Ingelman B. Untersuchungen über dextran und sein verhalten bei parenteraler. Zufuhr I. Acta Physiol. Scand. 7:1944;97-107.
11. Grönwall A., Ingelman B. Untersuchungen über dextran und sein verhalten bei parenteraler zufuhr II. Acta Physiol. Scand. 9:1945;1-27.
12. Guyton J.R., Klemp K.F., Mims M.P. Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescens of lipid domains forming droplets and vescicles. J. Lipid Res. 32:1991;953-962.
13. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
14. Helmstedt M., Stejskal J. Interpretation of static light scattering mesurements by two-component separation. Int. J. Polym. Anal. Charact. 4:1997;219-230.
15. Hoogeveen N.G., Hoogendam C.W., Tuinier R., Cohen Stuart M.A. Adsorption of weak polyelectrolytes on amphoteric oxide surfaces. Int. J. Polym. Anal. Charact. 1:1995;315-328.
16. Keler-Bacoka M., Pucar Z. Lipid changes caused by colloidal dextran added to human sera in different volume ratios. Clin. Lipid Res. 37:1966;2638-2649.
17. Koksch M., Rühlmann C., Arnhold J., Wiegel D. In vitro effects of low molecular weight dextran on the surface properties of LDL. Z. Gesamte Inn. Med. 47:1992;535-537.
18. La Belle M., Krauss R.M. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J. Lipid Res. 31:1990;1577-1588.
19. 2 particles. Colloids Surf. 66:1992;189-195.
20. Liu H., Scraba D.G., Ryan R.O. Prevention of phospholipase-C induced aggregation of low-density lipoprotein by amphipatic apoproteins. FEBS Lett. 3106:1993;27-33.
21. 2+-induced oxidation. Biochem. J. 310:1995;417-426.
22. Millaud B., Strazielle C. Diffusion Rayleigh dans le rouge par les solutions de polymeres. Makrom. Chem. 180:1979;441-453.
23. Mollison A.W., Rennie J.B. Treatment of renal oedema with dextran. Br. Med. J. 1:1954;893-899.
24. Nievelstein-Post P., Mottino G., Fogelman A., Frank J. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler. Thromb. 14:1994;1151-1161.
25. Nordmeier E. Static and dynamic light-scattering solution behaviour of pullulan and dextran in comparison. J. Phys. Chem. 97:1993;5770-5785.
26. Öörni K., Hakala J.K., Annila A., Ala-Korpela M., Kovanen P.T. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation of low-density lipoprotein (LDL) particles. Two distinct mechanisms leading to increasing binding strength of LDL to human aortic proteoglycans. J. Biol. Chem. 273:1998;29127-29134.
27. Pentikäinen M.O., Lehtonen E.M., Kovanen P.T. Aggregation and fusion of modified low-density lipoprotein. J. Lipid Res. 37:1995;2638-2649.
28. Pentikainen M.O., Lehtonen E.M., Öörni K., Lusa S., Somerharju P., Jauhiainen M., Kovanen P.T. Human arterial proteoclycans increase the rate of proteolytic fusion of low density lipoprotein particles. J. Biol. Chem. 272:1997;25283-25288.
29. Piha M., Lindstedt L., Kovanen P.T. Fusion of proteolyzed low-density lipoprotein in the fluid phase: a novel mechanism generating atherogenic lipoprotein particles. Biochemistry. 34:1995;10120-10129.
30. Provencher S.W. A constrained regularization method for inverting data represented by linear algebraic or integral equations. Comput. Phys. Commun. 27:1982;213-227.
31. Provencher S.W. CONTIN: a general purpose constrained regularization program for inverting noisy linear algebraic and integral equations. Comput. Phys. Commun. 27:1982;229-242.
32. Pucar Z., Keler-Bacoka M. Effect of molecular weights of colloidal dextran on human serum lipids. Science. 134:1961;1369-1370.
33. Rayleigh J.W. Proc. R. Soc. (Lond.). A84:1911;25-46.
34. Rühlmann C., Koksch M., Kuklinski B. Der einfluß nieder-und höhermolekularer dextrane auf ausgewählte lipidparameter im serum. 1. Mitteilung. Z. Gesamte Inn. Med. 47:1992;6-11.
35. Rühlmann C., Koksch M., Hohdorf K., Kuklinski B. Der einfluß nieder- und höhermolekularer dextrane auf ausgewählte lipidparameter im serum. 2. Mitteilung. Z. Gesamte Inn. Med. 47:1992;337-340.
36. Rühlmann C., Koksch M., Hohdorf K., Kuklinski B. Der einfluβ nieder-und höhermolekularer dextrane auf ausgewählte lipidparameter im serum. 3. Mitteilung. Z. Gesamte Inn. Med. 48:1993;381-385.
37. Shen M.M., Krauss R.M., Lindgren F.T., Forte T.M. Heterogeneity of serum low density lipoproteins in normal human subjects. J. Lipid. Res. 22:1981;236-244.
38. Tribble D.L., Holl L.G., Wood P.D., Krauss R.M. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 93:1992;189-199.
39. Vijayagopal P., Figueroa J.E., Fontenot J.D., Glancy D.L. Isolation and characterization of a proteoglycan variant from human aorta exhibiting a marked affinity for low density lipoprotein and demonstration of ist enhanced expression in atherosclerotic plaques. Atherosclerosis. 127:1996;195-203.
40. Whitehead T.P., Dykes P.W., Gloster J., Harris P. The effect of low molecular weight dextran infusions on plasma lipids and lipoproteins. Clin. Sci. 38:1970;233-244.
41. Zhang W.Y., Gaynor P.M., Kruth H.S. Aggregated low density lipoprotein induces and enters surface-connected compartments of human monocyte-macrophages. Uptake occurs independently of the low density lipoprotein receptor. J. Biol. Chem. 272:1997;31700-31706.